A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer

Kearney, Matthew R.; Chen, Emerson Y.; Vaccaro, Gina M.; Strother, John; Burt, Andrea; Todd, Kendra; Donovan, Jeff; Kampa-Schittenhelm, Kerstin M.; Lopez, Charles D.

dc.contributor.author	Kampa-Schittenhelm, Kerstin Maria
dc.date.accessioned	2020-06-22T05:59:13Z
dc.date.available	2020-06-22T05:59:13Z
dc.date.issued	2019
dc.identifier.issn	1791-7530
dc.identifier.uri	http://hdl.handle.net/10900/101682
dc.language.iso	en	de_DE
dc.publisher	Int Inst Anticancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.21873/anticanres.13104	de_DE
dc.subject.ddc	610	de_DE
dc.title	A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_03336
utue.publikation.seiten	245-252	de_DE
utue.personen.roh	Kearney, Matthew R.
utue.personen.roh	Chen, Emerson Y.
utue.personen.roh	Vaccaro, Gina M.
utue.personen.roh	Strother, John
utue.personen.roh	Burt, Andrea
utue.personen.roh	Todd, Kendra
utue.personen.roh	Donovan, Jeff
utue.personen.roh	Kampa-Schittenhelm, Kerstin M.
utue.personen.roh	Lopez, Charles D.
dcterms.isPartOf.ZSTitelID	Anticancer Research	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	39	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE